Since REST regulates KIF15 expression and subsequent cell cycle progression dependent on P300 and its HAT activity in GBM cells, we reasonably supposed HAT inactivity of P300 might sensitize GBM to cell cycle inhibitor treatment. This evidence concerns the gene KIF15 and glioblastoma.